Celecoxib promotes survival and upregulates the expression of neuroprotective marker genes in two different in vitro models of Parkinson's disease

Sarah Dassati, Rüdiger Schweigreiter, Susanne Buechner, Andreas Waldner

Open source

DOI
10.1016/j.neuropharm.2020.108378
Published
2021-08
Container
Neuropharmacology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.neuropharm.2020.108378,
  title = {Celecoxib promotes survival and upregulates the expression of neuroprotective marker genes in two different in vitro models of Parkinson's disease},
  author = {Sarah Dassati and Rüdiger Schweigreiter and Susanne Buechner and Andreas Waldner},
  year = {2021},
  journal = {Neuropharmacology},
  doi = {10.1016/j.neuropharm.2020.108378},
  url = {https://doi.org/10.1016/j.neuropharm.2020.108378}
}

RIS

TY  - JOUR
TI  - Celecoxib promotes survival and upregulates the expression of neuroprotective marker genes in two different in vitro models of Parkinson's disease
AU  - Sarah Dassati
AU  - Rüdiger Schweigreiter
AU  - Susanne Buechner
AU  - Andreas Waldner
PY  - 2021
JO  - Neuropharmacology
DO  - 10.1016/j.neuropharm.2020.108378
UR  - https://doi.org/10.1016/j.neuropharm.2020.108378
ER  - 

APA

Dassati, S., Schweigreiter, R., Buechner, S., & Waldner, A. (2021). Celecoxib promotes survival and upregulates the expression of neuroprotective marker genes in two different in vitro models of Parkinson's disease. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2020.108378

Source records